Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,216 followers.

@profgiordanoa #SHRO #cancer #cancertreatment #chemo #lungcancer #sbarroinstitute #drantoniogiordano

07 Aug 2021

Reply Repost Favourite

Research Paper: "Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade" Link: https://t.co/wt3jfAcHLz @profgiordanoa #SHRO #cancer #cancertreatment #

06 Aug 2021

Reply Repost Favourite

New research: Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade: Peripheral-immune-checkpoint blockade (P-ICB) with mAbs to PD-1… https://t.co/iuiiax

14 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.